EUVIMEDScopri EUVIMED
Open access

Development of a HiBiT Peptide-Based NanoBRET Ligand Binding Assay for Galanin Receptor 1 in Live Cells

Hu Zhu, Harrison C Daly iD, Tae Gyun Yang, Josh Born, Gisela Andrea Camacho-Hernandez, Mingyang Yuan, Mari Inglese, Vinoth Kumar Chenniappan, Kris Zimmerman, Robin Hurst, Xin Hu, Amy Hauck Newman iD and 4 more

ACS Chemical Biology · 2025

DOI: 10.1021/acschembio.5c00166 ↗

At a glance

Journal article in ACS Chemical Biology, 2025. Written by Hu Zhu and 15 co-authors. Institution: Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Mar…. Major MEDLINE topics: Galanin, Bioluminescence Resonance Energy Transfer Techniques, Peptides. 49 references. The full text is freely available in PubMed Central. Funded by: Intramural NIH HHS, Intramural Research Program, National Institutes of Health.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Galanin is a neuroendocrine peptide that regulates a wide range of physiological functions, including feeding and energy homeostasis, mood and anxiety, and modulation of pain. The function of the galanin peptide is mediated through its three galanin receptors, namely, GALR1, GALR2, and GALR3, which belong to the G protein-coupled receptor family. To measure the interaction of ligands with galanin receptor 1 (GALR1) in living cells, we developed a novel HiBiT peptide-based NanoBRET ligand binding assay. We generated six bioluminescence resonance energy transfer (BRET) tracers composed of modified and truncated galanin peptide derivatives tagged with a 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) acceptor fluorophore. The fluorophore-tagged peptide tracers were evaluated in cells expressing GALR1 tagged with HiBiT, an 11-amino acid subunit of NanoLuc, which, upon high affinity complementation with the cell-impermeable subunit LgBiT, reconstituted a functional NanoLuc luciferase. Addition of the furimazine substrate induced BRET to the BODIPY fluorophore acceptor component of the galanin-derived peptide tracers and produced a fluorescence signal output. Using this BRET assay, we characterized the binding affinity and binding kinetics of tracers with GALR1 in both equilibrium and real time. To validate our assay, we evaluated the binding affinity and function of a panel of unmodified galanin-derived peptide ligands through the competitive displacement of bound fluorescent galanin tracers. Our data showed that the binding affinity of these galanin peptide ligands correlated well with their rank order in β-arrestin recruitment and internalization functional assays. This study demonstrates that the HiBiT peptide-based NanoBRET ligand binding assay is a valuable system for studying the ligand engagement of GALR1 in living cells, offering an alternative to neuropeptide radioligand binding assays.

Subjects

MeSH terms (MEDLINE)

GalaninBioluminescence Resonance Energy Transfer TechniquesPeptidesHumansLigandsProtein BindingHEK293 CellsBoron CompoundsAnimalsFluorescent Dyes

Substances

LigandsGalaninPeptidesBoron Compounds4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneFluorescent Dyes

Authors and institutions

  • Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States.
  • Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, Maryland United States.
  • Promega Corporation, Fitchburg, Wisconsin 53711, United States.
  • Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, Maryland United States.

ORCID profiles: Harrison C Daly, Amy Hauck Newman, Sergi Ferré, Matthew D Hall, Samarjit Patnaik

Funding

  • Intramural NIH HHS
  • Intramural Research Program
  • National Institutes of Health

Cite

APA

Zhu, H., Daly, H. C., Yang, T. G., Born, J., Camacho-Hernandez, G. A., Yuan, M., Inglese, M., Chenniappan, V. K., Zimmerman, K., Hurst, R., Hu, X., Newman, A. H., Ferré, S., Ohana, R. F., Hall, M. D., & Patnaik, S. (2025). Development of a HiBiT Peptide-Based NanoBRET Ligand Binding Assay for Galanin Receptor 1 in Live Cells. ACS Chemical Biology. https://doi.org/10.1021/acschembio.5c00166

Vancouver

Zhu H, Daly HC, Yang TG, Born J, Camacho-Hernandez GA, Yuan M, et al. Development of a HiBiT Peptide-Based NanoBRET Ligand Binding Assay for Galanin Receptor 1 in Live Cells. ACS Chemical Biology. 2025. doi:10.1021/acschembio.5c00166

BibTeX
@article{Zhu2025,
  author = {Zhu, Hu and Daly, Harrison C and Yang, Tae Gyun and Born, Josh and Camacho-Hernandez, Gisela Andrea and Yuan, Mingyang and Inglese, Mari and Chenniappan, Vinoth Kumar and Zimmerman, Kris and Hurst, Robin and Hu, Xin and Newman, Amy Hauck and Ferré, Sergi and Ohana, Rachel Friedman and Hall, Matthew D and Patnaik, Samarjit},
  title = {Development of a HiBiT Peptide-Based NanoBRET Ligand Binding Assay for Galanin Receptor 1 in Live Cells},
  journal = {ACS Chemical Biology},
  year = {2025},
  doi = {10.1021/acschembio.5c00166}
}
Start for free →